To determine whether suppression of EGFR signalling is sufficient to inhibit the growth of FLCN−/− tumours, FTC-133 cells were injected subcutaneously into nude mice (5 × 106 cells per mouse). The gene discussed is EGFR; the disease is neoplasm.